NCT04622462View on ClinicalTrials.gov

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 12, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Oral Neoplasm
Interventions
PROCEDURE

Standard of Care Histopathology

Assessment for mild, moderate, or severe dysplasia, and risk of progression to oral cancer

PROCEDURE

STRATICYTE Assessment

Assessment for risk of progression to oral cancer

Trial Locations (3)

T5M 3Z7

RECRUITING

Kingsway Oral & Maxillofacial Surgery, Edmonton

T6G 1C9

RECRUITING

University of Alberta, Edmonton

N6A 5C1

RECRUITING

Western University, London

All Listed Sponsors
lead

Proteocyte Diagnostics Inc.

INDUSTRY